Urol. praxi, 2014; 15(5): 241-243

Urinary dysfunction in patients with multiple sclerosis

MUDr.Eva Burešová, MUDr.Aleš Vidlář, Ph.D.
Urologická klinika LF UP a FN Olomouc

Multiple sclerosis is a systemic autoimmune disease of the central nervous system (CNS) with a typical onset in young adulthood, most

frequently between the ages of 20 and 40 years. Women are affected twice as often as men. The pathogenesis involves autoimmune

mechanisms. Chronic inflammation can attack any part of the CNS, but most commonly the cerebral cortex and the spinal cord. Neurological

deficiency is manifested by a wide spectrum of clinical problems, including voiding dysfunctions.

Keywords: multiple sclerosis, neurogenic bladder, detrusor-sphincter dyssynergia

Published: December 16, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Burešová E, Vidlář A. Urinary dysfunction in patients with multiple sclerosis. Urol. praxi. 2014;15(5):241-243.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Koldewinj EL, et al. Relation between lower urinary abnormalities and disease related parameters in multiple sclerosis. J Urol. 1995; 154: 169-173. Go to original source... Go to PubMed...
    2. Schulz-Lampel D, et al. Neurogene systemerkrankungen - Ursachen und Auswirkungen auf die Blassenfunction. Springer. Berlin-Heidelberg-New York. 1997. Go to original source...
    3. Betts ChD, et al. Urinary smyptoms and the neurological features of bladder dysfunction in multiple sclerosis. J Neurol Neurosurg Psychiatry 1993; 56: 342-248. Go to original source...
    4. Chancelor BV, et al. Mutliple sclerosis and diabetic neurogenic bladder. Atlas of Urodynamics. Baltimore. 1996: 183-196.
    5. Giannanntoni A, et al. Urological dysfunction and upper urinary tract involvement in multiple sclerosis patients. Neurourol Urodyn 1998; 2: 89. Go to original source...
    6. Blavais JG, et al. Vesicourethral dysfunction in multiple sclerosis. J Urol 1979; 122: 342. Go to original source... Go to PubMed...
    7. Truss MC, et al. A possible alternative to anticholinergics in the treatment of urgency and urge incontinence: from banch to bedside. Eur Urol 1998; 33(suppl 1): 9. Go to PubMed...
    8. Cameron AP, et al. Combination drug therapy improves compliance of the neurogenic bladder. J Urol 2009; 182(3): 1062-1067. Go to original source... Go to PubMed...
    9. Angulo J, et al. Tadalafil enhances the inhibitory effects of tamsulosin on neurogenic contractions of human prostate and bladder neck. J Sex Med 2012; 9(9): 2293-2306. Go to original source... Go to PubMed...
    10. Barendrecht MM, et al. Is the use of parasympathomimetics for treating an underactive urinary bladder evidence-based? BJU Int 2007; 99(4): 749-752. Go to original source... Go to PubMed...
    11. Vereecken RL, et al. Long-term alpha-adreergic blocking therapy in detrusor urethra dyssynergia. Eur Urol 1983; 9: 16. Go to original source... Go to PubMed...
    12. Woodbury MG, et al. Intermittent catheterization practices following spinal cord injury: a National survey. Can J Urol 2008; 15(3): 4065-4071.
    13. Madersbacher H, et al. Wertigkeit der peripheren Elektrostimulation bei neurogener Blasenentleerungsstörung. Urologe (B) 1996; 36: 172.
    14. Kaplan WE. Intravesical electrical stimulation of the bladder: pro. Urology 2000; 56(1): 2-4. Go to original source... Go to PubMed...
    15. Cruz F, et al. Efficacy and safety of ona botulinumtoxin-A in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial. Eur Urol 2011; 60(4): 742-750. Go to original source... Go to PubMed...
    16. Reitz A, et al. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 2004; 45(4): 510-155. Go to original source... Go to PubMed...
    17. Haferkamp A, Schurch B, Reitz A, et al. Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type a in overactive neurogenic bladder. Eur Urol 2004 Dec; 46(6): 784-791. Go to original source... Go to PubMed...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.